Harvard School of Public Health » Gabriel Sanfelix-Gimeno

Home > Gabriel Sanfelix-Gimeno > Publications

Publications

Sanfélix-Genovés J, Sanfélix-Gimeno G, Peiró S, Hurtado I, Fluixà C, Fuertes A, Campos JC, Giner V, Baixauli C. Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort. Osteoporos Int. 2012 May 23.

Sanfélix-Genovés J, Arana E, Sanfélix-Gimeno G, Peiró S, Graells-Ferrer M, Vega-Martínez M. Agreement between semi-automatic radiographic morphometry and Genant semi-quantitative method in the assessment of vertebral fractures. Osteoporos Int. 2012 Aug;23(8):2129-34

Catalá-López F, Gènova-Maleras R, Ridao M, Alvarez E, Sanfélix-Gimeno G, Morant C, Peiró S. Burden of disease assessment with summary measures of population health for the Region of Valencia, Spain: a population-based study. Med Clin (Barc). 2012 Apr 10.

Sanfélix-Gimeno G, Ferreros I, Librero J, Peiró S. [Characterization of folate supplementation in pregnancy, based on a combination of health information systems.]. Gac Sanit. 2012 Mar 28.

Sanfélix-Gimeno G, Peiró S, Meneu R. [Pharmaceutical prescription in primary care. SESPAS report 2012]. Gac Sanit. 2012 Mar;26 Suppl 1:41-5.

Librero J, Peiró S, Leutscher E, Merlo J, Bernal-Delgado E, Ridao M, Martínez-Lizaga N, Sanfélix-Gimeno G. Timing of surgery for hip fracture and in-hospital mortality: a retrospective population-based cohort study in the Spanish National Health System. BMC Health Serv Res. 2012 Jan 18;12:15.

Catalá-López F, Sanfélix-Gimeno G, García-Torres C, Ridao M, Peiró S. Control of arterial hypertension in Spain: a systematic review and meta-analysis of 76 epidemiological studies on 341?632 participants. J Hypertens. 2012 Jan;30(1):168-76.

Catalá-López F, Alonso-Arroyo A, Aleixandre-Benavent R, Ridao M, Bolaños M, García-Altés A, Sanfélix-Gimeno G, Peiró S. Coauthorship and institutional collaborations on cost-effectiveness analyses: a systematic network analysis. PLoS One. 2012;7(5):e38012.

González López-Valcárcel B, Librero J, Sanfélix-Gimeno G, Peiró S; Group for Drug Utilization Research in the Spanish National Health System (IUM-SNS Group). Are prescribing doctors sensitive to the price that their patients have to pay in the Spanish National Health System? BMC Health Serv Res. 2011 Dec 8;11:333.

Peiró Moreno S, Cervera-Casino P, Sanfélix-Gimeno G, Librero López J. Trends in gastrointestinal bleeding in the Region of Valencia (2000-2005). Relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medication. Farm Hosp. 2011;35:289-97.

Sanfélix-Gimeno G, Sanfélix-Genovés J, Peiró S, Hurtado I, Trillo JL, Usó R, Ruiz VG, de la Torre MP, Ferreros I. Adherence to and appropriateness of anti-osteoporotic treatments in patients aged 50 and over in the Valencia Region (Spain). The ESOSVAL-AD study. BMC Musculoskelet Disord. 2011;12:178.

Sanfélix-Genovés J, Hurtado I, Sanfélix-Gimeno G, Reig-Molla B, Peiró S. Impact of osteoporosis and vertebral fractures on quality-of-life. A population-based study in Valencia, Spain (The FRAVO Study). Health Qual Life Outcomes. 2011;9:20.

Sanfélix-Genovés J, Peiró S, Sanfélix-Gimeno G, Hurtado I, Pascual de la Torre M, Trillo-Mata JL, Giner-Ruiz V. Impact of a multifaceted intervention to improve the clinical management of osteoporosis. The ESOSVAL-F study. BMC Health Serv Res. 2010;10:292.

Sanfélix-Genovés J, Reig-Molla B, Sanfélix-Gimeno G, Peiró S, Graells-Ferrer M, Vega-Martínez M, Giner V. The population-based prevalence of osteoporotic vertebral fracture and densitometric osteoporosis in postmenopausal women over 50 in Valencia, Spain (the FRAVO study). Bone. 2010 Sep;47(3):610-6.

Sanfélix-Gimeno G, Peiró S, Librero J; Grupo de Investigación en Utilización de Medicamentos en el Sistema Nacional de Salud (Grupo IUM-SNS) de la Comunidad Valenciana. [Variations in antihypertensive drug utilization among primary care areas in the autonomous region of Valencia (Spain)]. Gac Sanit. 2010;24:397-403.

Sanfélix-Gimeno G, Peiró S, Librero J, Ausejo-Segura M, Suárez-Alemán C, Molina-López T, Concepción CM, Castaño-Riera E; Grupo IUM-SNS. [Population analysis by area of health of changes in consumption, price and expenditure of cardiovascular drugs in eight autonomous communities, Spain, 2005]. Rev Esp Salud Publica. 2010;84:389-407.

Sanfélix-Genovés J, Peiró S, Sanfélix-Gimeno G, Giner V, Gil V, Pascual M, Fluixá C, Fuertes A, Hurtado I, Ferreros I. Development and validation of a population-based prediction scale for osteoporotic fracture in the region of Valencia, Spain: the ESOSVAL-R study. BMC Public Health. 2010;10:153.

Sanfélix-Gimeno G, Cervera-Casino P, Peiró S, López-Valcarcel BG, Blázquez A, Barbera T. Effectiveness of safety warnings in atypical antipsychotic drugs: an interrupted time-series analysis in Spain. Drug Saf. 2009;32:1075-87.

Sanfélix-Gimeno G, Ferreros I, Librero J, Peiró S. [Characterization of folate supplementation in pregnancy, based on a combination of health information systems.]. Gac Sanit. 2012 Mar 28.

Sanfélix-Gimeno G, Peiró S, Meneu R. [Pharmaceutical prescription in primary care. SESPAS report 2012]. Gac Sanit. 2012 Mar;26 Suppl 1:41-5.

Sanfélix-Gimeno G, Reig-Mollá B, Sanfélix-Genovés J, Giner-Ruiz V. [Effectiveness of drugs used in degenerative joint diseases (arthroses)]. Med Clin (Barc). 2008 Apr 5;130(12):463-5.

Sanfélix-Gimeno G, Reig-Mollá B, Sanfélix-Genovés J, Giner-Ruiz V. [Review of the evidence about drugs used as SYSADOA]. Med Clin (Barc). 2007 Nov 3;129(16):624-8.